Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 39 entries
Sorted by: Best Match Show Resources per page
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma.

Sarcoma

Dickson MA, D'Adamo DR, Keohan ML, D'Angelo SP, Carvajal RD, Gounder MM, Maki RG, Qin LX, Lefkowitz RA, McKennon OR, Hirst CM, Schwartz GK, Tap WD.
PMID: 26074722
Sarcoma. 2015;2015:532478. doi: 10.1155/2015/532478. Epub 2015 May 14.

Gemcitabine (G) and docetaxel (D) are commonly used to treat recurrent/metastatic soft tissue sarcoma. This study tested the hypothesis that outcomes would be improved by addition of bevacizumab (B). The initial design was randomized double-blind trial of G +...

Cite
Dickson MA, D'Adamo DR, Keohan ML, et al. Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma. Sarcoma. 2015;2015:532478doi: 10.1155/2015/532478.
Dickson, M. A., D'Adamo, D. R., Keohan, M. L., D'Angelo, S. P., Carvajal, R. D., Gounder, M. M., Maki, R. G., Qin, L. X., Lefkowitz, R. A., McKennon, O. R., Hirst, C. M., Schwartz, G. K., & Tap, W. D. (2015). Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma. Sarcoma, 2015532478. https://doi.org/10.1155/2015/532478
Dickson, Mark A, et al. "Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma." Sarcoma vol. 2015 (2015): 532478. doi: https://doi.org/10.1155/2015/532478
Dickson MA, D'Adamo DR, Keohan ML, D'Angelo SP, Carvajal RD, Gounder MM, Maki RG, Qin LX, Lefkowitz RA, McKennon OR, Hirst CM, Schwartz GK, Tap WD. Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma. Sarcoma. 2015;2015:532478. doi: 10.1155/2015/532478. Epub 2015 May 14. PMID: 26074722; PMCID: PMC4446476.
Copy Download .nbib Format: NLM
Preoperative carbohydrate nutrition reduces postoperative nausea and vomiting compared to preoperative fasting.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Yilmaz N, Cekmen N, Bilgin F, Erten E, Ozhan MÖ, Coşar A.
PMID: 24497851
J Res Med Sci. 2013 Oct;18(10):827-32.

BACKGROUND: The aim of this prospective, randomized, single-blinded study was to compare the effects of a carbohydrate drink 400 mL given 2 h before the surgery with preoperative overnight fasting on the gastric pH and residual volume, postoperative nausea...

Cite
Yilmaz N, Cekmen N, Bilgin F, et al. Preoperative carbohydrate nutrition reduces postoperative nausea and vomiting compared to preoperative fasting. J Res Med Sci. 2013;18(10):827-32
Yilmaz, N., Cekmen, N., Bilgin, F., Erten, E., Ozhan, M. �. �., & Coşar, A. (2013). Preoperative carbohydrate nutrition reduces postoperative nausea and vomiting compared to preoperative fasting. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 18(10), 827-32.
Yilmaz, Neslihan, et al. "Preoperative carbohydrate nutrition reduces postoperative nausea and vomiting compared to preoperative fasting." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 18,10 (2013): 827-32.
Yilmaz N, Cekmen N, Bilgin F, Erten E, Ozhan MÖ, Coşar A. Preoperative carbohydrate nutrition reduces postoperative nausea and vomiting compared to preoperative fasting. J Res Med Sci. 2013 Oct;18(10):827-32. PMID: 24497851; PMCID: PMC3897064.
Copy Download .nbib Format: NLM
Do the patients read the informed consent?.

Balkan medical journal

Ozhan MÖ, Süzer MA, Comak I, Caparlar CÖ, Aydın GB, Eşkin MB, Atik B, Ergin A, Cekmen N, Kurt E.
PMID: 25207184
Balkan Med J. 2014 Jun;31(2):132-6. doi: 10.5152/balkanmedj.2014.13212. Epub 2014 Jun 01.

BACKGROUND: Informed consent is a process which consists of informing the patient about the medical interventions planned to be applied to the patient's body and making the patient active in the decision making process.AIMS: The aim of this study...

Cite
Ozhan MÖ, Süzer MA, Comak I, et al. Do the patients read the informed consent?. Balkan Med J. 2014;31(2):132-6doi: 10.5152/balkanmedj.2014.13212.
Ozhan, M. �. �., Süzer, M. A., Comak, I., Caparlar, C. �. �., Aydın, G. B., Eşkin, M. B., Atik, B., Ergin, A., Cekmen, N., & Kurt, E. (2014). Do the patients read the informed consent?. Balkan medical journal, 31(2), 132-6. https://doi.org/10.5152/balkanmedj.2014.13212
Ozhan, Mehmet Özgür, et al. "Do the patients read the informed consent?." Balkan medical journal vol. 31,2 (2014): 132-6. doi: https://doi.org/10.5152/balkanmedj.2014.13212
Ozhan MÖ, Süzer MA, Comak I, Caparlar CÖ, Aydın GB, Eşkin MB, Atik B, Ergin A, Cekmen N, Kurt E. Do the patients read the informed consent?. Balkan Med J. 2014 Jun;31(2):132-6. doi: 10.5152/balkanmedj.2014.13212. Epub 2014 Jun 01. PMID: 25207184; PMCID: PMC4115924.
Copy Download .nbib Format: NLM
Long term follow-up and patterns of response, progression and hyperprogression in patients after PD-1 blockade in advanced sarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research

Klemen ND, Hwang S, Bradic M, Rosenbaum E, Dickson MA, Gounder MM, Kelly CM, Keohan ML, Movva S, Thornton KA, Chi P, Nacev BA, Chan JE, Bartlett EK, Richards AL, Singer S, Donoghue MTA, Tap WD, D'Angelo SP.
PMID: 34965948
Clin Cancer Res. 2021 Dec 29; doi: 10.1158/1078-0432.CCR-21-3445. Epub 2021 Dec 29.

PURPOSE: PD-1 blockade can mediate objective responses in advanced sarcomas, but their durability has not been established and it is unclear if hyperprogressive disease (HPD) occurs in sarcomas treated with PD-1 inhibitors.METHODS: We pooled patients who were treated prospectively...

Cite
Klemen ND, Hwang S, Bradic M, et al. Long term follow-up and patterns of response, progression and hyperprogression in patients after PD-1 blockade in advanced sarcoma. Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-3445.
Klemen, N. D., Hwang, S., Bradic, M., Rosenbaum, E., Dickson, M. A., Gounder, M. M., Kelly, C. M., Keohan, M. L., Movva, S., Thornton, K. A., Chi, P., Nacev, B. A., Chan, J. E., Bartlett, E. K., Richards, A. L., Singer, S., Donoghue, M. T. A., Tap, W. D., & D'Angelo, S. P. (2021). Long term follow-up and patterns of response, progression and hyperprogression in patients after PD-1 blockade in advanced sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-3445
Klemen, Nicholas D, et al. "Long term follow-up and patterns of response, progression and hyperprogression in patients after PD-1 blockade in advanced sarcoma." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-3445
Klemen ND, Hwang S, Bradic M, Rosenbaum E, Dickson MA, Gounder MM, Kelly CM, Keohan ML, Movva S, Thornton KA, Chi P, Nacev BA, Chan JE, Bartlett EK, Richards AL, Singer S, Donoghue MTA, Tap WD, D'Angelo SP. Long term follow-up and patterns of response, progression and hyperprogression in patients after PD-1 blockade in advanced sarcoma. Clin Cancer Res. 2021 Dec 29; doi: 10.1158/1078-0432.CCR-21-3445. Epub 2021 Dec 29. PMID: 34965948.
Copy Download .nbib Format: NLM
Proning modus operandi in pregnancies complicated by acute respiratory distress syndrome secondary to COVID-19.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Cojocaru L, Turan OM, Levine A, Sollecito L, Williams S, Elsamadicy E, Crimmins S, Turan S.
PMID: 34915799
J Matern Fetal Neonatal Med. 2021 Dec 16;1-10. doi: 10.1080/14767058.2021.2013464. Epub 2021 Dec 16.

INTRODUCTION: Prone positioning has been widely utilized in ARDS management before and during the COVID-19 pandemic due to its demonstrated mortality benefits. In pregnancy, proning requires careful attention to often overlooked physiologic changes in pregnancy and additional technical challenges...

Cite
Cojocaru L, Turan OM, Levine A, et al. Proning modus operandi in pregnancies complicated by acute respiratory distress syndrome secondary to COVID-19. J Matern Fetal Neonatal Med. 2021;1-10doi: 10.1080/14767058.2021.2013464.
Cojocaru, L., Turan, O. M., Levine, A., Sollecito, L., Williams, S., Elsamadicy, E., Crimmins, S., & Turan, S. (2021). Proning modus operandi in pregnancies complicated by acute respiratory distress syndrome secondary to COVID-19. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-10. https://doi.org/10.1080/14767058.2021.2013464
Cojocaru, Liviu, et al. "Proning modus operandi in pregnancies complicated by acute respiratory distress syndrome secondary to COVID-19." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2021): 1-10. doi: https://doi.org/10.1080/14767058.2021.2013464
Cojocaru L, Turan OM, Levine A, Sollecito L, Williams S, Elsamadicy E, Crimmins S, Turan S. Proning modus operandi in pregnancies complicated by acute respiratory distress syndrome secondary to COVID-19. J Matern Fetal Neonatal Med. 2021 Dec 16;1-10. doi: 10.1080/14767058.2021.2013464. Epub 2021 Dec 16. PMID: 34915799.
Copy Download .nbib Format: NLM
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes.

JCO precision oncology

Rosenbaum E, Jonsson P, Seier K, Qin LX, Chi P, Dickson M, Gounder M, Kelly C, Keohan ML, Nacev B, Donoghue MTA, Chiang S, Singer S, Ladanyi M, Antonescu CR, Hensley ML, Movva S, D'Angelo SP, Tap WD.
PMID: 33283135
JCO Precis Oncol. 2020 Nov 06;4. doi: 10.1200/PO.20.00122. eCollection 2020.

PURPOSE: To detect alterations in DNA damage repair (DDR) genes, measure homologous recombination deficiency (HRD), and correlate these findings with clinical outcome in patients with leiomyosarcoma (LMS).PATIENTS AND METHODS: Patients with LMS treated at Memorial Sloan Kettering (MSK) Cancer...

Cite
Rosenbaum E, Jonsson P, Seier K, et al. Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes. JCO Precis Oncol. 2020;4doi: 10.1200/PO.20.00122.
Rosenbaum, E., Jonsson, P., Seier, K., Qin, L. X., Chi, P., Dickson, M., Gounder, M., Kelly, C., Keohan, M. L., Nacev, B., Donoghue, M. T. A., Chiang, S., Singer, S., Ladanyi, M., Antonescu, C. R., Hensley, M. L., Movva, S., D'Angelo, S. P., & Tap, W. D. (2020). Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes. JCO precision oncology, 4. https://doi.org/10.1200/PO.20.00122
Rosenbaum, Evan, et al. "Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes." JCO precision oncology vol. 4 (2020). doi: https://doi.org/10.1200/PO.20.00122
Rosenbaum E, Jonsson P, Seier K, Qin LX, Chi P, Dickson M, Gounder M, Kelly C, Keohan ML, Nacev B, Donoghue MTA, Chiang S, Singer S, Ladanyi M, Antonescu CR, Hensley ML, Movva S, D'Angelo SP, Tap WD. Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes. JCO Precis Oncol. 2020 Nov 06;4. doi: 10.1200/PO.20.00122. eCollection 2020. PMID: 33283135; PMCID: PMC7713532.
Copy Download .nbib Format: NLM
Surgical advances in the management of placenta accreta spectrum: establishing new expectations for operative blood loss.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Cojocaru L, Lankford A, Galey J, Bharadwaj S, Kodali BS, Kennedy K, Goetzinger K, Turan OM.
PMID: 33272057
J Matern Fetal Neonatal Med. 2020 Dec 03;1-10. doi: 10.1080/14767058.2020.1852213. Epub 2020 Dec 03.

OBJECTIVE: To evaluate whether the implementation of our surgical approach, referred to in the text as Linear Cutter Vessel Sealing System (LCVSS) technique, will improve perioperative outcomes in patients with placenta accreta spectrum (PAS), specifically by reducing blood loss...

Cite
Cojocaru L, Lankford A, Galey J, et al. Surgical advances in the management of placenta accreta spectrum: establishing new expectations for operative blood loss. J Matern Fetal Neonatal Med. 2020;1-10doi: 10.1080/14767058.2020.1852213.
Cojocaru, L., Lankford, A., Galey, J., Bharadwaj, S., Kodali, B. S., Kennedy, K., Goetzinger, K., & Turan, O. M. (2020). Surgical advances in the management of placenta accreta spectrum: establishing new expectations for operative blood loss. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-10. https://doi.org/10.1080/14767058.2020.1852213
Cojocaru, Liviu, et al. "Surgical advances in the management of placenta accreta spectrum: establishing new expectations for operative blood loss." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2020): 1-10. doi: https://doi.org/10.1080/14767058.2020.1852213
Cojocaru L, Lankford A, Galey J, Bharadwaj S, Kodali BS, Kennedy K, Goetzinger K, Turan OM. Surgical advances in the management of placenta accreta spectrum: establishing new expectations for operative blood loss. J Matern Fetal Neonatal Med. 2020 Dec 03;1-10. doi: 10.1080/14767058.2020.1852213. Epub 2020 Dec 03. PMID: 33272057.
Copy Download .nbib Format: NLM
Activated Protein Phosphatase 2A Disrupts Nutrient Sensing Balance Between Mechanistic Target of Rapamycin Complex 1 and Adenosine Monophosphate-Activated Protein Kinase, Causing Sarcopenia in Alcohol-Associated Liver Disease.

Hepatology (Baltimore, Md.)

Davuluri G, Welch N, Sekar J, Gangadhariah M, Alsabbagh Alchirazi K, Mohan ML, Kumar A, Kant S, Thapaliya S, Stine M, McMullen MR, McCullough RL, Stark GR, Nagy LE, Naga Prasad SV, Dasarathy S.
PMID: 32799332
Hepatology. 2021 May;73(5):1892-1908. doi: 10.1002/hep.31524. Epub 2021 Apr 20.

BACKGROUND AND AIMS: Despite the high clinical significance of sarcopenia in alcohol-associated cirrhosis, there are currently no effective therapies because the underlying mechanisms are poorly understood. We determined the mechanisms of ethanol-induced impaired phosphorylation of mechanistic target of rapamycin...

Cite
Davuluri G, Welch N, Sekar J, et al. Activated Protein Phosphatase 2A Disrupts Nutrient Sensing Balance Between Mechanistic Target of Rapamycin Complex 1 and Adenosine Monophosphate-Activated Protein Kinase, Causing Sarcopenia in Alcohol-Associated Liver Disease. Hepatology. 2021;73(5):1892-1908doi: 10.1002/hep.31524.
Davuluri, G., Welch, N., Sekar, J., Gangadhariah, M., Alsabbagh Alchirazi, K., Mohan, M. L., Kumar, A., Kant, S., Thapaliya, S., Stine, M., McMullen, M. R., McCullough, R. L., Stark, G. R., Nagy, L. E., Naga Prasad, S. V., & Dasarathy, S. (2021). Activated Protein Phosphatase 2A Disrupts Nutrient Sensing Balance Between Mechanistic Target of Rapamycin Complex 1 and Adenosine Monophosphate-Activated Protein Kinase, Causing Sarcopenia in Alcohol-Associated Liver Disease. Hepatology (Baltimore, Md.), 73(5), 1892-1908. https://doi.org/10.1002/hep.31524
Davuluri, Gangarao, et al. "Activated Protein Phosphatase 2A Disrupts Nutrient Sensing Balance Between Mechanistic Target of Rapamycin Complex 1 and Adenosine Monophosphate-Activated Protein Kinase, Causing Sarcopenia in Alcohol-Associated Liver Disease." Hepatology (Baltimore, Md.) vol. 73,5 (2021): 1892-1908. doi: https://doi.org/10.1002/hep.31524
Davuluri G, Welch N, Sekar J, Gangadhariah M, Alsabbagh Alchirazi K, Mohan ML, Kumar A, Kant S, Thapaliya S, Stine M, McMullen MR, McCullough RL, Stark GR, Nagy LE, Naga Prasad SV, Dasarathy S. Activated Protein Phosphatase 2A Disrupts Nutrient Sensing Balance Between Mechanistic Target of Rapamycin Complex 1 and Adenosine Monophosphate-Activated Protein Kinase, Causing Sarcopenia in Alcohol-Associated Liver Disease. Hepatology. 2021 May;73(5):1892-1908. doi: 10.1002/hep.31524. Epub 2021 Apr 20. PMID: 32799332.
Copy Download .nbib Format: NLM
Antenatal Fetal Adrenal Measurements at 22 to 30 Weeks' Gestation, Fetal Growth Restriction, and Perinatal Morbidity.

American journal of perinatology

Blue NR, Hoffman M, Allshouse AA, Grobman WA, Simhan HN, Turan OM, Parry S, Chung JH, Reddy U, Haas DM, Myers S, Mercer B, Saade GR, Silver RM.
PMID: 31756754
Am J Perinatol. 2021 Jun;38(7):676-682. doi: 10.1055/s-0039-3400308. Epub 2019 Nov 22.

OBJECTIVE: Our objective was to test the association of fetal adrenal size with perinatal morbidity among fetuses with fetal growth restriction (FGR; estimated fetal weight [EFW] 

Cite
Blue NR, Hoffman M, Allshouse AA, et al. Antenatal Fetal Adrenal Measurements at 22 to 30 Weeks' Gestation, Fetal Growth Restriction, and Perinatal Morbidity. Am J Perinatol. 2019;38(7):676-682doi: 10.1055/s-0039-3400308.
Blue, N. R., Hoffman, M., Allshouse, A. A., Grobman, W. A., Simhan, H. N., Turan, O. M., Parry, S., Chung, J. H., Reddy, U., Haas, D. M., Myers, S., Mercer, B., Saade, G. R., & Silver, R. M. (2021). Antenatal Fetal Adrenal Measurements at 22 to 30 Weeks' Gestation, Fetal Growth Restriction, and Perinatal Morbidity. American journal of perinatology, 38(7), 676-682. https://doi.org/10.1055/s-0039-3400308
Blue, Nathan R, et al. "Antenatal Fetal Adrenal Measurements at 22 to 30 Weeks' Gestation, Fetal Growth Restriction, and Perinatal Morbidity." American journal of perinatology vol. 38,7 (2021): 676-682. doi: https://doi.org/10.1055/s-0039-3400308
Blue NR, Hoffman M, Allshouse AA, Grobman WA, Simhan HN, Turan OM, Parry S, Chung JH, Reddy U, Haas DM, Myers S, Mercer B, Saade GR, Silver RM. Antenatal Fetal Adrenal Measurements at 22 to 30 Weeks' Gestation, Fetal Growth Restriction, and Perinatal Morbidity. Am J Perinatol. 2021 Jun;38(7):676-682. doi: 10.1055/s-0039-3400308. Epub 2019 Nov 22. PMID: 31756754; PMCID: PMC7708295.
Copy Download .nbib Format: NLM
Sex and sensitive period differences in potential effects of maltreatment on axial versus radial diffusivity in the corpus callosum.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Ohashi K, Anderson CM, Khan A, Rohan ML, Bolger EA, McGreenery CE, Teicher MH.
PMID: 35022536
Neuropsychopharmacology. 2022 Jan 12; doi: 10.1038/s41386-021-01260-7. Epub 2022 Jan 12.

Corpus callosum (CC) abnormalities have been observed in several psychiatric disorders. Maltreatment has also been associated with marked differences in CC anatomy and microstructure, though rarely controlled for in psychiatric neuroimaging studies. The aim of this study was to...

Cite
Ohashi K, Anderson CM, Khan A, et al. Sex and sensitive period differences in potential effects of maltreatment on axial versus radial diffusivity in the corpus callosum. Neuropsychopharmacology. 2022;doi: 10.1038/s41386-021-01260-7.
Ohashi, K., Anderson, C. M., Khan, A., Rohan, M. L., Bolger, E. A., McGreenery, C. E., & Teicher, M. H. (2022). Sex and sensitive period differences in potential effects of maltreatment on axial versus radial diffusivity in the corpus callosum. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, . https://doi.org/10.1038/s41386-021-01260-7
Ohashi, Kyoko, et al. "Sex and sensitive period differences in potential effects of maltreatment on axial versus radial diffusivity in the corpus callosum." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. (2022). doi: https://doi.org/10.1038/s41386-021-01260-7
Ohashi K, Anderson CM, Khan A, Rohan ML, Bolger EA, McGreenery CE, Teicher MH. Sex and sensitive period differences in potential effects of maltreatment on axial versus radial diffusivity in the corpus callosum. Neuropsychopharmacology. 2022 Jan 12; doi: 10.1038/s41386-021-01260-7. Epub 2022 Jan 12. PMID: 35022536.
Copy Download .nbib Format: NLM
The rate of undetectable genetic causes by Cell-free DNA test in congenital heart defects.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Asoglu MR, Cutting EM, Ozdemir H, Higgs AS, Siegel GB, Turan OM, Turan S.
PMID: 32338089
J Matern Fetal Neonatal Med. 2020 Apr 26;1-7. doi: 10.1080/14767058.2020.1757643. Epub 2020 Apr 26.

No abstract available.

Cite
Asoglu MR, Cutting EM, Ozdemir H, et al. The rate of undetectable genetic causes by Cell-free DNA test in congenital heart defects. J Matern Fetal Neonatal Med. 2020;1-7doi: 10.1080/14767058.2020.1757643.
Asoglu, M. R., Cutting, E. M., Ozdemir, H., Higgs, A. S., Siegel, G. B., Turan, O. M., & Turan, S. (2020). The rate of undetectable genetic causes by Cell-free DNA test in congenital heart defects. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-7. https://doi.org/10.1080/14767058.2020.1757643
Asoglu, Mehmet Resit, et al. "The rate of undetectable genetic causes by Cell-free DNA test in congenital heart defects." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2020): 1-7. doi: https://doi.org/10.1080/14767058.2020.1757643
Asoglu MR, Cutting EM, Ozdemir H, Higgs AS, Siegel GB, Turan OM, Turan S. The rate of undetectable genetic causes by Cell-free DNA test in congenital heart defects. J Matern Fetal Neonatal Med. 2020 Apr 26;1-7. doi: 10.1080/14767058.2020.1757643. Epub 2020 Apr 26. PMID: 32338089.
Copy Download .nbib Format: NLM
F-18 Fdg PET/CT Findings of a Patient with Takayasu Arteritis Before and After Therapy.

Molecular imaging and radionuclide therapy

Sağer S, Yılmaz S, Ozhan M, Halaç M, Ergül N, Ciftci H, Cermik TF.
PMID: 23486556
Mol Imaging Radionucl Ther. 2012 Apr;21(1):32-4. doi: 10.4274/Mirt.021896. Epub 2012 Apr 01.

UNLABELLED: Vasculitis is defined as inflammation and necrosis with leukocytic infiltration of the blood vessel wall. Takayasu arteritis is a chronic inflammatory arteritis that primarily involves the aorta and its main branches. A 64-year-old female patient with a 2-month...

Cite
Sağer S, Yılmaz S, Ozhan M, et al. F-18 Fdg PET/CT Findings of a Patient with Takayasu Arteritis Before and After Therapy. Mol Imaging Radionucl Ther. 2012;21(1):32-4doi: 10.4274/Mirt.021896.
Sağer, S., Yılmaz, S., Ozhan, M., Halaç, M., Ergül, N., Ciftci, H., & Cermik, T. F. (2012). F-18 Fdg PET/CT Findings of a Patient with Takayasu Arteritis Before and After Therapy. Molecular imaging and radionuclide therapy, 21(1), 32-4. https://doi.org/10.4274/Mirt.021896
Sağer, Sait, et al. "F-18 Fdg PET/CT Findings of a Patient with Takayasu Arteritis Before and After Therapy." Molecular imaging and radionuclide therapy vol. 21,1 (2012): 32-4. doi: https://doi.org/10.4274/Mirt.021896
Sağer S, Yılmaz S, Ozhan M, Halaç M, Ergül N, Ciftci H, Cermik TF. F-18 Fdg PET/CT Findings of a Patient with Takayasu Arteritis Before and After Therapy. Mol Imaging Radionucl Ther. 2012 Apr;21(1):32-4. doi: 10.4274/Mirt.021896. Epub 2012 Apr 01. PMID: 23486556; PMCID: PMC3590965.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 39 entries